As of May 27
| +0.63 / +1.38%|
The 40 analysts offering 12-month price forecasts for Dr.Reddy's Laboratories Ltd have a median target of 48.81, with a high estimate of 64.29 and a low estimate of 38.71. The median estimate represents a +5.45% increase from the last price of 46.29.
The current consensus among 39 polled investment analysts is to Hold stock in Dr.Reddy's Laboratories Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.